Clinical Trial Update: Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating peritumoral and periganglionic infiltration of levobupivacaine before conservative surgery in triple-negative breast cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• levobupivacaine (levobupivacaine)

Snippet

Sponsor: Institut Jean-Godinot | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING